Peggy Scherle
CIK: 0001824632
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRLD
Prelude Therapeutics Inc
Officer
Discretionary Trading P&L
Holdings
About Scherle Peggy
Scherle Peggy (SEC CIK 0001824632) files insider reports with the SEC as Chief Scientific Officer of Prelude Therapeutics Inc (PRLD).
Signal8 holds 2 ownership filings by Scherle Peggy, all Form 4s, filed between Feb 5, 2025 and Feb 5, 2026. Those filings report 2 transactions, from Feb 4, 2025 to Feb 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Scherle Peggy's filings is in WILMINGTON, DE.
Recent filings by Scherle Peggy
Other insiders filing for Prelude Therapeutics Inc (PRLD)
- BAKER BROS. ADVISORS LP, Director
- Dorton Katina, Director
- Babler Martin, Director
- Bonita David P, Director
- Sandor Victor, Director
- FRIEDMAN PAUL A, Director